Clinical impact of febrile neutropenia (FIN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer

被引：0
|
作者：
Hamilton, Erika Paige
Topping, Donna L.
Peppercorn, Jeffrey M.
Marcom, P. Kelly
Kimmick, Gretchen Genevieve
Duff, Erin
Cirrincione, Constance T.
Blackwell, Kimberly L.
机构：
[1] Duke Canc Inst, Durham, NC USA
[2] Duke Canc Inst Biostat, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1076
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in patients with breast cancer: A retrospective analysis
    Ngamphaiboon, N.
    Advani, P. P.
    O'Connor, T. L.
    Ademuyiwa, F. O.
    Levine, E. G.
    Riebandt, G.
    Kossoff, E. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Nuttapong Ngamphaiboon
    Tracey L. O’Connor
    Pooja P. Advani
    Ellis G. Levine
    Ellen B. Kossoff
    Medical Oncology, 2012, 29 : 1495 - 1501
  • [4] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Ngamphaiboon, Nuttapong
    O'Connor, Tracey L.
    Advani, Pooja P.
    Levine, Ellis G.
    Kossoff, Ellen B.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1495 - 1501
  • [5] Incidence of Febrile Neutropenia in Patients Treated with Docetaxel and Cyclophosphamide (TC) for Adjuvant Breast Cancer
    Yee, J.
    Chan, J.
    Fehrenbacher, L.
    Fredriks, D.
    Chen, D.
    Wong, W.
    Colley, D.
    CANCER RESEARCH, 2011, 71
  • [6] Primary prophylaxis of febrile neutropenia during adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer
    Yu, J. L.
    Kurin, M.
    Pasetka, M.
    Kiss, A.
    Chan, K.
    Sridhar, S. S.
    Warner, E.
    CANCER RESEARCH, 2013, 73
  • [7] Incidence of febrile neutropenia with use of docetaxel plus cyclophosphamide (TC) for breast cancer.
    Patel, Kiran
    Diergaarde, Brenda
    Brufsky, Adam
    Jankowitz, Rachel Catherine
    Lembersky, Barry C.
    Rastogi, Priya
    Huggins-Puhalla, Shannon Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Chemotherapy Induced Febrile Neutropenia of Docetaxel with Cyclophosphamide (TC) for Adjuvant Therapy of Breast Cancer in the Community-Reality Check
    Myers, R.
    Higgins, B.
    Jeffrey, M.
    Mova, L.
    Rajagopal, S.
    Jones, G.
    Stakiw, J.
    CANCER RESEARCH, 2009, 69 (24) : 623S - 623S
  • [9] Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, HongKi
    Park, Seon Young
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2020, 23 (05) : 521 - 532
  • [10] Febrile neutropenia rates during docetaxel and cyclophosphamide (TC) adjuvant therapy in early breast cancer (EBC)
    Kotasek, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345